Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

9.67
-0.0200-0.21%
Volume:50.82K
Turnover:481.56K
Market Cap:8.87M
PE:-0.04
High:9.83
Open:9.69
Low:9.31
Close:9.69
52wk High:191.80
52wk Low:6.08
Shares:916.97K
Float Shares:832.40K
Volume Ratio:2.11
T/O Rate:6.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-236.5200
EPS(LYR):-1,317.4218
ROE:-1763.01%
ROA:-232.54%
PB:6.22
PE(LYR):-0.01

Loading ...

May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Major Issues Report

8-K - Current report
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 09, 2022

Major Issues Report

8-K - Current report
Nov 30, 2022

Major Issues Report

8-K - Current report
Nov 30, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 28, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]